SPC188
Ibrutinib eða lyfjafræðilega nothæft salt þar af
Status:
HafnaðApplication date:
4.4.2017Application published:
15.4.2017
Max expiry date:
6.7.2030Medicine name:
ImbruvicaMedicine for children:
No
Timeline
Today
4.4.2017Application
15.4.2017Publication
6.7.2030Expires
Marketing license
IS authorization number:
EU/1/14/945/001-002Date:
18.11.2014
Foreign authorization number:
EU/1/14/945Date:
3.7.2015
Owner
Name:
Pharmacyclics LLCAddress:
1 North Waukegan Road, North Chicago, IL 60064 US
Agent
Name:
Ólafur Ragnarsson hrl., PaticeAddress:
Pósthólf 8236, 128 Reykjavík
Patent
Number:
EP2529621